Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder

JAMA - Journal of the American Medical Association

Volumn 314, Issue 9, 2015, Pages 595-903

  Tammimies, Kristiina ^a,b   Marshall, Christian R ^a,c   Walker, Susan ^a   Kaur, Gaganjot ^a   Thiruvahindrapuram, Bhooma ^a   Lionel, Anath C ^a   Yuen, Ryan K C ^a   Uddin, Mohammed ^a   Roberts, Wendy ^c   Weksberg, Rosanna ^c   Woodbury Smith, Marc ^d   Zwaigenbaum, Lonnie ^e   Anagnostou, Evdokia ^f   Wang, Zhuozhi ^a   Wei, John ^a   Howe, Jennifer L ^a   Gazzellone, Matthew J ^a   Lau, Lynette ^a,c   Sung, Wilson W L ^a   Whitten, Kathy ^g   Vardy, Cathy ^g,h   Crosbie, Victoria ^g,h   Tsang, Brian ^a   D'Abate, Lia ^a   Tong, Winnie W L ^a   Luscombe, Sandra ^g   Doyle, Tyna ^g,h   Carter, Melissa T ^c   Szatmari, Peter ^c   Stuckless, Susan ^h   Merico, Daniele ^a   Stavropoulos, Dimitri J ^c   Scherer, Stephen W ^a,i   Fernandez, Bridget A ^g,h   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f University of Toronto   (Canada)

^g Eastern Health Canada   (Canada)

^h MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; WNT1 PROTEIN;

ARTICLE; ASPERGER SYNDROME; AUTISM; CANADA; CHILD; CHROMOSOMAL MICROARRAY ANALYSIS; CHROMOSOME ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PHENOTYPE; PRIORITY JOURNAL; PTEN GENE; SCORING SYSTEM; WHOLE EXOME SEQUENCING; WNT1 GENE; AUTISTIC DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DNA MICROARRAY; DNA SEQUENCE; EXOME; GENETICS; MUTATION; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; SEQUENCE ANALYSIS; STATISTICS AND NUMERICAL DATA;

ASPERGER SYNDROME; AUTISTIC DISORDER; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; EXOME; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN;

EID: 84940764107     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.10078     Document Type: Article

References (50)

1. Prevalence of autism spectrum disorder among children aged 8 years: Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. Centers for Disease Control and Prevention. http://www.cdc.gov/mmwr/pdf/ss/ss6302.pdf. Accessed August 6, 2015.
2. th ed. Washington, DC: American Psychiatric Association; 2013.
3. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
4. Ozgen HM, Hop JW, Hox JJ, Beemer FA, van Engeland H. Minor physical anomalies in autism: a meta-analysis. Mol Psychiatry. 2010;15(3):300-307.
5. Manouilenko I, Eriksson JM, Humble MB, Bejerot S. Minor physical anomalies in adults with autism spectrum disorder and healthy controls. Autism Res Treat. 2014;2014:743482.
6. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012;22(3):229-237.
7. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.
8. Shen Y, Dies KA, Holm IA, et al Autism Consortium Clinical Genetics/DNA Diagnostics Collaboration. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics.2010; 125(4):e727-e735.
9. McGrew SG, Peters BR, Crittendon JA, Veenstra-Vanderweele J. Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement?J Autism Dev Disord. 2012;42(8):1582-1591.
10. De Rubeis S, He X, Goldberg AP, et al DDD Study; Homozygosity Mapping Collaborative for Autism; UK10K Consortium. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209-215.
11. Iossifov I, O'Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526):216-221.
12. Liu XQ, Paterson AD, Szatmari P; Autism Genome Project Consortium. Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biol Psychiatry. 2008;64(7):561-570.
13. Miles JH, Takahashi TN, Bagby S, et al. Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A. 2005;135(2):171-180.
14. Robinson EB, Samocha KE, Kosmicki JA, et al. Autism spectrum disorder severity reflects the average contribution of de novo and familial influences. Proc Natl Acad Sci U S A. 2014;111(42):15161-15165.
15. Uddin M, Tammimies K, Pellecchia G, et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder.Nat Genet. 2014;46(7):742-747.
16. nd ed. Oxford, UK: Oxford University Press; 2007.
17. Carter MT, Scherer SW. Autism spectrum disorder in the genetics clinic: a review. Clin Genet. 2013;83(5):399-407.
18. Gazzellone MJ, Zhou X, Lionel AC, et al. Copy number variation in Han Chinese individuals with autism spectrum disorder. J Neurodev Disord. 2014;6(1):34.
19. Lionel AC, Crosbie J, Barbosa N, et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med. 2011;3(95):95ra75.
20. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82(2):477-488.
21. Pinto D, Delaby E, Merico D, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014;94(5):677-694.
22. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680-685.
23. Marshall CR, Scherer SW. Detection and characterization of copy number variation in autism spectrum disorder. Methods Mol Biol. 2012;838:115-135.
24. NHLBI GO Exome Sequencing Project (ESP) exome variant server. esp6500si version http://evs.gs.washington.edu/EVS/. Accessed January 22, 2013.
25. Abecasis GR, Altshuler D, Auton A, et al; 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing [published correction in Nature. 2011;473(7348):544]. Nature. 2010;467(7319):1061-1073.
26. Jiang YH, Yuen RK, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet. 2013;93(2):249-263.
27. Richards S, Aziz N, Bale S, et al Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
28. Pyott SM, Tran TT, Leistritz DF, et al. WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am J Hum Genet. 2013;92(4):590-597.
29. Kalkman HO. A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism. 2012;3(1):10.
30. Wong VC, Fung CK, Wong PT. Use of dysmorphology for subgroup classification on autism spectrum disorder in Chinese children. J Autism Dev Disord. 2014;44(1):9-18.
31. Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12(11):742-745.
32. Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW; Autism Sequencing Consortium. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron. 2012;76(6):1052-1056.
33. Lionel AC, Tammimies K, Vaags AK, et al. Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Hum Mol Genet. 2014;23(10):2752-2768.
34. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880-1887.
35. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6(265):265ra168.
36. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870-1879.
37. Trottier M, Roberts W, Drmic I, et al. Parents' perspectives on participating in genetic research in autism. J Autism Dev Disord. 2013;43(3):556-568.
38. Narcisa V, Discenza M, Vaccari E, Rosen-Sheidley B, Hardan AY, Couchon E. Parental interest in a genetic risk assessment test for autism spectrum disorders. Clin Pediatr (Phila). 2013;52(2):139-146.
39. Baker E, Jeste SS. Diagnosis and management of autism spectrum disorder in the era of genomics: rare disorders can pave the way for targeted treatments. Pediatr Clin North Am. 2015;62(3):607-618.
40. Rosti RO, Sadek AA, Vaux KK, Gleeson JG. The genetic landscape of autism spectrum disorders. Dev Med Child Neurol. 2014;56(1):12-18.
41. Scherer SW, Dawson G. Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet. 2011;130(1):123-148.
42. Anagnostou E, Zwaigenbaum L, Szatmari P, et al. Autism spectrum disorder: advances in evidence-based practice. CMAJ. 2014;186(7):509-519.
43. Piven J, Vieland VJ, Parlier M, et al. A molecular genetic study of autism and related phenotypes in extended pedigrees. J Neurodev Disord. 2013;5(1):30.
44. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466(7304):368-372.
45. Yuen RK, Thiruvahindrapuram B, Merico D, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med. 2015;21(2):185-191.
46. di Rocco F, Baujat G, Arnaud E, et al. Clinical spectrum and outcomes in families with coronal synostosis and TCF12 mutations. Eur J Hum Genet. 2014;22(12):1413-1416.
47. Paumard-Hernández B, Berges-Soria J, Barroso E, et al. Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants.Eur J Hum Genet. 2015;23(7):907-914.
48. Sharma VP, Fenwick AL, Brockop MS, et al; 500 Whole-Genome Sequences (WGS500) Consortium. Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet. 2013;45(3):304-307.
49. Jacquemont S, Coe BP, Hersch M, et al. A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. Am J Hum Genet. 2014;94(3):415-425.
50. Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511(7509):344-347.